Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Aspirin Versus Rivaroxaban After Replacement of the Aortic Valve With a Biological Valve Prosthesis

NCT02974920 is registered in ClinicalTrials.gov with Christian Torp-Pedersen as lead sponsor.

NCT NCT02974920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02974920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Aspirin Versus Rivaroxaban After Replacement of the Aortic Valve With a Biological Valve Prosthesis
Lead sponsor
Christian Torp-Pedersen
Phase
Phase 4
Overall status
Unknown status
Start date
January 1, 2017
Completion date
November 30, 2022
Enrollment
1,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aortic regurgitation, aortic stenosis, thrombosis